Overview of Dr. Mitchell
Dr. Aaron Mitchell is an oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from New York University Grossman School of Medicine and has been in practice 5 years. He is one of 494 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. He has more than 100 publications and over 500 citings.
Office
353 East 68th Street
New York, NY 10065
Education & Training
- University of North Carolina HospitalsFellowship, Hematology and Medical Oncology, 2015 - 2018
- Duke University HospitalResidency, Internal Medicine, 2011 - 2014
- New York University School of MedicineClass of 2011
Certifications & Licensure
- FL State Medical License 2021 - Present
- NJ State Medical License 2019 - 2025
- NY State Medical License 2018 - 2025
- NC State Medical License 2011 - 2019
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 235 citationsIdentification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors.Cameron M. Douglas, J A D'Ippolito, G J Shei, Maria S. Meinz, Janet C. Onishi
Antimicrobial Agents and Chemotherapy. 1997-11-01 - 38 citationsThree regulatory systems control production of glutamine synthetase in Saccharomyces cerevisiae.Aaron P. Mitchell, Boris Magasanik
Molecular and Cellular Biology. 1984-12-01 - 29 citationsStatin cost effectiveness in primary prevention: A systematic review of the recent cost-effectiveness literature in the United StatesAaron P. Mitchell, Ross J. Simpson
BMC Research Notes. 2012-07-24
Journal Articles
- Function of BriC Peptide in the Pneumococcal Competence and Virulence PortfolioWenjie Xu, Aaron P Mitchell, PLoS One
Press Mentions
- FDA Gets Drugs Out Faster, but Some Work Only ‘Marginally’ Better and Are More Expensive • Daily MontananOctober 13th, 2024
- Study in India Could Make Immunotherapy More Affordable WorldwideNovember 22nd, 2022
- Pharma-Funded FDA Gets Drugs Out Faster, but Some Work Only ‘Marginally’ and Most Are PriceySeptember 30th, 2022
- Join now to see all
Grant Support
- Functional Analysis Of Essential C. Albicans GenesNational Institute Of Allergy And Infectious Diseases2012
- Genetic Control Of C. Albicans Biofilm FormationNational Institute Of Allergy And Infectious Diseases2009–2012
- PROTEIN-PROTEIN Interaction Test In Candida AlbicansNational Institute Of Allergy And Infectious Diseases2009–2010
- Genetic Control Of Entry Into Meiosis In YeastNational Institute Of Allergy And Infectious Diseases2008–2010
- Large-Scale Analysis Of Candida Albicans Gene FunctionNational Institute Of Allergy And Infectious Diseases2008
- ASM Conference On Candida And CandidiasisNational Institute Of Allergy And Infectious Diseases2008
- Genetic Control Of C. Albicans Biofilm FormationNational Institute Of Allergy And Infectious Diseases2006–2008
- Molecular Mycology Summer CourseNational Institute Of Allergy And Infectious Diseases2003–2008
- Genetic Control Of Entry Into Meiosis In YeastNational Institute Of Allergy And Infectious Diseases2006–2007
- Large-Scale Analysis Of Candida Albicans Gene FunctionNational Institute Of Allergy And Infectious Diseases2004–2007
- 2006 Cellular &Molecular Fungal Biology Gordon Research ConferenceNational Institute Of Allergy And Infectious Diseases2006
- Training Program In Microbiology For Infectious DiseasesNational Institute Of Allergy And Infectious Diseases2004–2006
- C. Albicans Regulatory Pathways In Oral CandidiasisNational Institute Of Allergy And Infectious Diseases2001–2005
- New Strategies For Identification Of C. Albicans Fluconazole Resistance GeneNational Institute Of Allergy And Infectious Diseases2004
- Genetic Control Of Entry Into Meiosis In YeastNational Institute Of General Medical Sciences1995–2004
- Identification Of C Albicans Fluconazole Resistance GeneNational Institute Of Allergy And Infectious Diseases2003
- Identification And Evaluation Of Anti-Candida Vaccine TargetsNational Institute Of Allergy And Infectious Diseases1999–2002
- Genetic Control Of Entry Into Meiosis In YeastNational Institute Of General Medical Sciences1988–1994
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: